Interview
In conversation with
Nadine Rohloff
Dr. Nadine Rohloff is bringing women’s health into everyday care with Endo Health, starting from the Endo-App—an on-prescription, evidence-based companion for endometriosis covered by Germany’s public insurers (DiGA). Think multimodal therapy—medical, psychological, nutritional, physiotherapeutic—available 24/7 and extended to dysmenorrhea, PMS, menopause, and PCOS. The north star is simple and demanding: patient-centred design, rigorous science, and real data protection—so digital support is trusted, equitable, and truly useful.
Let’s use technology not to replace the human touch in healthcare but to protect it.
Lessons from App-on-Prescription Women’s Health:
Evidence Before Scale
Rohloff’s route runs from university gynecology to entrepreneurship, turning frontline insight into a reimbursed digital companion that patients can access for free via prescription. The operating model is B2B2C: work with the system, not around it; involve physicians and patients in product decisions; and treat scientific quality, user experience, and privacy as non-negotiables. She argues progress depends on balancing privacy, IT security, usability, and responsible data use—enabling research and real-world evidence without drowning innovation in paperwork. Leadership means robust change management, designing for clinicians’ workflows (not just patients’), and resisting “digitalization” that merely copies broken processes. On capital, she’s pragmatic: raise with a clear plan and the right partners; remember grants and bootstrapping are valid paths; and look beyond Europe only if expansion warrants it. The throughline: put outcomes and consent first, then scale multimodal support across adjacent indications—so women are seen, supported, and believed.
What we cover
-
How on-prescription digital companions make multimodal therapy accessible in endometriosis and beyond
-
Why balancing privacy, security, usability, and research access unlocks trustworthy digital health
-
What change management leaders need to guide clinicians, patients, and teams through new workflows
-
Where funding strategies diverge—grants, bootstrapping, or VC—and when to look outside Europe
-
Which principles keep products credible: evidence first, patient-centred design, and meaningful consent
Nadine Rohloff is a physician, co-founder and CEO of Endo Health GmbH, and serves as the medical director of the Endo-App. She previously worked at the Department of Gynecology at the University of Münster, gaining extensive clinical and research experience in the care of patients with endometriosis. Today, she is committed to advancing digital health solutions that improve access to care, provide reliable medical information, and offer individualized support in women’s health.
About
Dr. med. Nadine Rohloff
Connect
